Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine Maintenance After XELOX in Advanced Gastric Cancer
NCT02038621Phase 2Unknown
- Sponsor
- Second People's Hospital of Sichuan
- Start
- Jan 2014
- Primary completion
- Dec 2016
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 2 trial of capecitabine in gastric cancer (GC), sponsored by Second People's Hospital of Sichuan. Status: unknown.
02
Drugs
capecitabine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02038621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038621.